Esther Scheirlynck1, Monica Chivulescu2, Øyvind H Lie2, Andreea Motoc1, Jorgos Koulalis1, Carlo de Asmundis3, Juan Sieira3, Gian-Battista Chierchia3, Pedro Brugada3, Bernard Cosyns1, Thor Edvardsen3, Steven Droogmans1, Kristina H Haugaa4. 1. Centrum voor Hart-en Vaatziekten, Universitair Ziekenhuis Brussel- Vrije Universiteit Brussel, Brussels, Belgium. 2. Department of Cardiology, Oslo University Hospital, Rikshospitalet-Institute for Clinical Medicine, University of Oslo, Oslo, Norway. 3. Heart Rhythm Management Center, Centrum voor Hart-en Vaatziekten Universitair Ziekenhuis Brussel -Vrije Universiteit Brussel, Postgraduate program in Cardiac Electrophysiology and Pacing, European Reference Network GUARD-Heart, Brussels, Belgium. 4. Department of Cardiology, Oslo University Hospital, Rikshospitalet-Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: kristina.haugaa@medisin.uio.no.
Abstract
OBJECTIVES: This study aimed to assess the presence of echocardiographic and electrocardiographic similarities in patients with Brugada syndrome (BrS) and arrhythmogenic cardiomyopathy (AC) and the prevalence and prognostic value of AC structural/electrical features in patients with BrS. BACKGROUND: BrS and AC are genetic cardiac diseases with high risk for sudden cardiac death. Although BrS and AC display different features, previous reports suggest a phenotypic overlap. METHODS: We acquired clinical data, electrocardiogram, and transthoracic echocardiography in patients with BrS and AC. We assessed the presence of AC diagnostic criteria according to the 2010 AC task force criteria for right ventricular outflow tract (RVOT), fractional area change, depolarization, and repolarization in the patients with BrS. We compared arrhythmic outcome in BrS patients with and without AC structural/electrical criteria. RESULTS: A total of 116 BrS and 141 AC patients were included. AC electrical features were present in 28 (24%) BrS patients and structural features in 97 (84%) BrS patients. BrS patients with an RVOT or depolarization AC criterion showed a trend towards worse severe arrhythmia-free survival compared to BrS patients without (p = 0.05). The criterion for RVOT dilation showed high sensitivity and improved detection of arrhythmic BrS patients when added to type 1 electrocardiogram pattern and syncope (area under the curve 0.73 [95% confidence interval: 0.59 to 0.87] vs. area under the curve 0.79 [95% confidence interval: 0.69 to 0.90]); p = 0.009). CONCLUSIONS: In this large cohort comparison, Brugada syndrome (BrS) and arrhythmogenic cardiomyopathy patients had phenotypic overlap. The presence of arrhythmogenic cardiomyopathy diagnostic criteria in BrS patients was associated with a trend towards higher arrhythmic risk. The right ventricular outflow tract dilation criterion improved detection of arrhythmic BrS patients.
OBJECTIVES: This study aimed to assess the presence of echocardiographic and electrocardiographic similarities in patients with Brugada syndrome (BrS) and arrhythmogenic cardiomyopathy (AC) and the prevalence and prognostic value of AC structural/electrical features in patients with BrS. BACKGROUND: BrS and AC are genetic cardiac diseases with high risk for sudden cardiac death. Although BrS and AC display different features, previous reports suggest a phenotypic overlap. METHODS: We acquired clinical data, electrocardiogram, and transthoracic echocardiography in patients with BrS and AC. We assessed the presence of AC diagnostic criteria according to the 2010 AC task force criteria for right ventricular outflow tract (RVOT), fractional area change, depolarization, and repolarization in the patients with BrS. We compared arrhythmic outcome in BrS patients with and without AC structural/electrical criteria. RESULTS: A total of 116 BrS and 141 AC patients were included. AC electrical features were present in 28 (24%) BrS patients and structural features in 97 (84%) BrS patients. BrS patients with an RVOT or depolarization AC criterion showed a trend towards worse severe arrhythmia-free survival compared to BrS patients without (p = 0.05). The criterion for RVOT dilation showed high sensitivity and improved detection of arrhythmic BrSpatients when added to type 1 electrocardiogram pattern and syncope (area under the curve 0.73 [95% confidence interval: 0.59 to 0.87] vs. area under the curve 0.79 [95% confidence interval: 0.69 to 0.90]); p = 0.009). CONCLUSIONS: In this large cohort comparison, Brugada syndrome (BrS) and arrhythmogenic cardiomyopathypatients had phenotypic overlap. The presence of arrhythmogenic cardiomyopathy diagnostic criteria in BrS patients was associated with a trend towards higher arrhythmic risk. The right ventricular outflow tract dilation criterion improved detection of arrhythmic BrSpatients.
Authors: Antonio Oliva; Simone Grassi; Vilma Pinchi; Francesca Cazzato; Mónica Coll; Mireia Alcalde; Marta Vallverdú-Prats; Alexandra Perez-Serra; Estefanía Martínez-Barrios; Sergi Cesar; Anna Iglesias; José Cruzalegui; Clara Hernández; Victoria Fiol; Elena Arbelo; Nuria Díez-Escuté; Vincenzo Arena; Josep Brugada; Georgia Sarquella-Brugada; Ramon Brugada; Oscar Campuzano Journal: J Clin Med Date: 2022-07-28 Impact factor: 4.964
Authors: P J Peltenburg; Y M Hoedemaekers; S A B Clur; N A Blom; A C Blank; E P Boesaard; S Frerich; F van den Heuvel; A A M Wilde; J A E Kammeraad Journal: Neth Heart J Date: 2022-10-12 Impact factor: 2.854
Authors: Nicolò Martini; Martina Testolina; Gian Luca Toffanin; Rocco Arancio; Luca De Mattia; Sergio Cannas; Giovanni Morani; Bortolo Martini Journal: J Clin Med Date: 2021-03-02 Impact factor: 4.241
Authors: Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada Journal: Biomedicines Date: 2022-01-05